Loaded with siRNA targeting anti-CSF-1R to inhibit the survival of M2 TAMs, these nanoparticles could lead to selective depletion, tumor regression, and prolong the survival of B16 melanoma-bearing mice [186]. The gene discussed is CSF1R; the disease is neoplasm.